How America Got Hooked on Deadly Opioids
Purdue Pharma bought more than $18 million worth of advertising in major medical journals that cheerily touted OxyContin, and in some ads “grossly overstated” the drug’s safety.
Purdue Pharma bought more than $18 million worth of advertising in major medical journals that cheerily touted OxyContin, and in some ads “grossly overstated” the drug’s safety.
Here you'll find all collections you've created before.